Information  X 
Enter a valid email address

Axis Bank Ltd (AXB)

  Print      Mail a friend

Tuesday 22 October, 2019

Axis Bank Ltd

ALLOTMENT OF EQUITY SHARES UNDER ESOP

RNS Number : 7243Q
Axis Bank Limited
22 October 2019
 

07.10.2019

                                               

Dear Sirs,                     

 

SUB: QUARTERLY REPORTING - ALLOTMENT OF EQUITY SHARES UNDER ESOP - AXIS BANK

 

Please note that the Bank had allotted equity shares under ESOP Scheme of the Bank during the quarter ending on 30th September 2019 are as follows:

 

Allotment Date

Equity Shares Issued (Face Value - Rs. 2/-)

Post Issued Paid Up Capital

No of Shares

(Face Value - Rs. 2/-)

Paid Up Capital (Rs) -

(Face Value - Rs. 2/-)

01-07-2019

75,877

2,61,95,95,388

5,23,91,90,776

08-07-2019

15,050

2,61,96,10,438

5,23,92,20,876

15-07-2019

1,03,300

2,61,97,13,738

5,23,94,27,476

22-07-2019

41,050

2,61,97,54,788

5,23,95,09,576

29-07-2019

44,515

2,61,97,99,303

5,23,95,98,606

13-08-2019

2,26,771

2,62,00,26,074

5,24,00,52,148

19-08-2019

53,800

2,62,00,79,874

5,24,01,59,748

26-08-2019

74,215

2,62,01,54,089

5,24,03,08,178

03-09-2019

78,650

2,62,02,32,739

5,24,04,65,478

09-09-2019

8,325

2,62,02,41,064

5,24,04,82,128

16-09-2019*

35,250

2,62,02,76,314

5,24,05,52,628

30-09-2019

1,51,180

2,81,91,55,633

5,63,83,11,266

 

*Please note that the Bank has issued and allotted 198,728,139 equity shares of Rs. 2/- each of the Bank pursuant to Qualified Institutional Placement Issue on 26th September 2019. Pursuant to the allotment of the said equity shares, the total issued and paid up share capital of the Bank has increased to Rs. 563,80,08,906/- (281,90,04,453 equity shares of Rs. 2/- each).

 

 

You are requested to take the above on record.

 

 

For Axis Bank Limited

 

 

Girish Koliyote

Company Secretary

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCMTBMTMBATBBL

a d v e r t i s e m e n t